Christopher Kirby

Deputy General Counsel at Boston Children's Hospital

Chris Kirby joined Boston Children’s Hospital as Deputy General Counsel in February 2015.  His main areas of practice are commercial transactions, international, investments, technology transfer, and general business matters.  Prior to coming to Boston Children’s Hospital, Chris served in leadership positions in the biotechnology industry, as General Counsel of FORMA Therapeutics, LLC and Vice President and Global Head Legal, Biosurgery and Renal of Sanofi (formerly Genzyme Corporation).  While at Genzyme, Chris also represented the clinical laboratory unit through its sale to Laboratory Corporation of America in 2010.  Chris began his legal career as an Associate at Ropes & Gray LLP.  Chris received his B.A. cum laude from the University of Pennsylvania, his J.D. with honors from The George Washington University Law School, and his MPH from the George Washington University Milken Institute School of Public Health.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.